COOPER COMPANIES, INC.
COONasdaq · SIC 3851
$71.71
↓ -1.9%Jul 17 close · end-of-day
Price
1Y↓ -1.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$14.0B
Enterprise Value
$16.3B
P/E
61.3
P/S
3.3
P/B
1.7
EV/EBITDA
18.4
PEG
—
FCF Yield
4.1%
Dividend Yield
—
Revenue (TTM)
$4.2B
Net Income (TTM)
$235.8M
Free Cash Flow (TTM)
$569.5M
Gross Margin
65.5%
Operating Margin
11.8%
Net Margin
5.6%
ROE
2.9%
ROIC
2.7%
Debt / Equity
0.3
Net Cash
-$2.3B
Return 1Y
-2.1%
Company profile
CooperVision and CooperSurgical segments provide medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients. CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon.
- CEO
- Albert G. White
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 14,000
- Headquarters
- California
- Website
- coopercos.com
Management & directors
- Andrews Brian GEVP, CFO & Treasurer
- Mcbride Daniel GEVP & Chief Operating Officer
- Sheffield Holly RPresident, CSI
- Warner Gerard H IiiPresident, CooperVision, Inc.
- White Albert G IiiPresident & CEO
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-09-03
COO Q2 2026 Earnings
Period ends 2026-04-30
MetricActualYoY
Revenue$1.1B↑ +7.9%
Diluted EPS-$0.40↓ -190.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.9B | $3.3B | $3.6B | $3.9B | $4.1B |
| Gross profit | $1.5B | $2.0B | $2.1B | $2.4B | $2.6B | $2.7B |
| Operating income | $311.8M | $505.8M | $507.6M | $533.1M | $705.7M | $682.9M |
| Net income | $238.4M | $2.9B | $385.8M | $294.2M | $392.3M | $374.9M |
| Diluted EPS | $4.81 | $59.16 | $1.94 | $1.48 | $1.96 | $1.87 |
| Operating cash flow | $486.6M | $738.6M | $692.4M | $607.5M | $709.3M | $796.1M |
| Free cash flow | $176.2M | $524.2M | $450.4M | $215.0M | $288.1M | $433.7M |
| Gross margin | 63.1% | 66.9% | 64.7% | 65.6% | 66.6% | 65.5% |
| Operating margin | 12.8% | 17.3% | 15.3% | 14.8% | 18.1% | 16.7% |
| Net margin | 9.8% | 100.8% | 11.7% | 8.2% | 10.1% | 9.2% |
| Line item | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $964.7M | $1.0B | $1.1B | $1.1B | $1.0B | $1.1B |
| Gross profit | $663.0M | $677.7M | $660.2M | $679.1M | $692.0M | $650.8M | $695.2M | $735.4M |
| Operating income | $192.5M | $198.4M | $182.0M | $184.8M | $175.7M | $140.4M | $212.8M | -$31.0M |
| Net income | $104.7M | $117.5M | $104.3M | $87.7M | $98.3M | $84.6M | $130.8M | -$77.9M |
| Diluted EPS | $0.52 | $0.59 | $0.52 | $0.44 | $0.49 | $0.42 | $0.66 | -$0.40 |
| Operating cash flow | $207.5M | $268.1M | $190.6M | $96.2M | $261.4M | $247.9M | $260.9M | $182.8M |
| Free cash flow | $118.5M | $128.1M | $101.2M | $18.1M | $164.5M | $149.9M | $158.7M | $96.4M |
| Gross margin | 66.1% | 66.5% | 68.4% | 67.8% | 65.3% | 61.1% | 67.9% | 68.0% |
| Operating margin | 19.2% | 19.5% | 18.9% | 18.4% | 16.6% | 13.2% | 20.8% | -2.9% |
| Net margin | 10.4% | 11.5% | 10.8% | 8.7% | 9.3% | 7.9% | 12.8% | -7.2% |
Company news
Jul 16, 2026
Jun 30, 2026
- 20d agoCooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosurefinance.yahoo.com
- 20d agoIs COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressurefinance.yahoo.com
- 20d agoHow COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?finance.yahoo.com
- 20d agoHow COO Is Riding Myopia and Fertility Trends Amid Execution Risksfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-01 | Rosebrough Walter M Jr | Option exercise | 832 | $0.00 | $0.00 | filing |
| 2026-04-01 | WEISS ROBERT S | Option exercise | 3,654 | $0.00 | $0.00 | filing |
| 2026-04-01 | Rivas Maria | Option exercise | 3,322 | $0.00 | $0.00 | filing |
| 2026-04-01 | Jay Colleen | Option exercise | 3,322 | $0.00 | $0.00 | filing |
| 2026-04-01 | Carbone Barbara | Option exercise | 3,050 | $0.00 | $0.00 | filing |
| 2026-04-01 | MADDEN TERESA S | Option exercise | 3,322 | $0.00 | $0.00 | filing |
| 2026-04-01 | Lucchese Cynthia L | Option exercise | 3,322 | $0.00 | $0.00 | filing |
| 2026-04-01 | Kurzius Lawrence Erik | Option exercise | 3,322 | $0.00 | $0.00 | filing |
| 2026-01-12 | Jay Colleen | Option exercise | 7,064 | $39.40 | $278,321.60 | filing |
| 2026-01-08 | White Albert G III· President & CEO | Tax withholding | 9,419 | $83.13 | $783,001.47 | filing |
| 2026-01-08 | McBride Daniel G· EVP & Chief Operating Officer | Tax withholding | 2,415 | $83.13 | $200,758.95 | filing |
| 2026-01-08 | McBride Daniel G· EVP & Chief Operating Officer | Tax withholding | 2,121 | $83.13 | $176,318.73 | filing |
| 2026-01-08 | McBride Daniel G· EVP & Chief Operating Officer | Tax withholding | 2,119 | $83.13 | $176,152.47 | filing |
| 2026-01-08 | Andrews Brian G· EVP, CFO & Treasurer | Tax withholding | 1,893 | $83.13 | $157,365.09 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Tax withholding | 1,714 | $83.13 | $142,484.82 | filing |
| 2026-01-08 | Sheffield Holly R· President, CSI | Tax withholding | 1,641 | $83.13 | $136,416.33 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Tax withholding | 1,501 | $83.13 | $124,778.13 | filing |
| 2026-01-08 | Sheffield Holly R· President, CSI | Tax withholding | 1,462 | $83.13 | $121,536.06 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Tax withholding | 1,354 | $83.13 | $112,558.02 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Tax withholding | 787 | $83.13 | $65,423.31 | filing |
| 2026-01-08 | Sheffield Holly R· President, CSI | Tax withholding | 738 | $83.13 | $61,349.94 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Tax withholding | 629 | $83.13 | $52,288.77 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Option exercise | 1,232 | $0.00 | $0.00 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Option exercise | 3,154 | $0.00 | $0.00 | filing |
| 2026-01-08 | Warner Gerard H III· President, CooperVision, Inc. | Option exercise | 2,652 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.